Expression and functional studies, in macrophages as well as in vivo, suggested Gilz as the primary candidate for explaining the LPS-resistance in SPRET/Ei mice and as an important novel protective factor in endotoxemia. This evidence concerns the gene TSC22D3 and serum lipopolysaccharide activity.